Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group.

Data for the effects on blood pressure of renal artery balloon angioplasty are mostly from uncontrolled studies. The aim of this study was to document the efficacy and safety of angioplasty for lowering blood pressure in patients with atherosclerotic renal artery stenosis. Patients were randomly assigned antihypertensive drug treatment (control group, n = 26) or angioplasty (n = 23). Twenty-four-hour ambulatory blood pressure, the primary end point, was measured at baseline and at termination. Termination took place 6 months after randomization or earlier in patients who developed refractory hypertension. In those allocated angioplasty, antihypertensive treatment was discontinued after the procedure but was subsequently resumed if hypertension persisted. Secondary end points were the treatment score and the incidence of complications. Two patients in the control group and 6 in the angioplasty group suffered procedural complications (relative risk, 3.4; 95% confidence interval, 0.8 to 15.1). Early termination was required for refractory hypertension in 7 patients in the control group. Antihypertensive treatment was resumed in 17 patients in the angioplasty group. Mean ambulatory blood pressure at termination did not differ between control (141+/-15/84+/-11 mm Hg) and angioplasty (140+/-15/81+/-9 mm Hg) groups. Angioplasty reduced by 60% the probability of having a treatment score of 2 or more at termination (relative risk, 0.4; 95% confidence interval, 0.2 to 0.7). There was 1 case of dissection with segmental renal infarction and 3 of restenosis in the angioplasty group. No patient suffered renal artery thrombosis. In unilateral atherosclerotic renal artery stenosis, angioplasty is a drug-sparing procedure that involves some morbidity. Previous uncontrolled and unblinded assessments of angioplasty overestimated its potential for lowering blood pressure.

[1]  M. Jamieson,et al.  An evaluation of the A&D UA-751 semi-automated cuff-oscillometric sphygmomanometer. , 1990, Journal of hypertension.

[2]  L. Prisant,et al.  Variability of indirect methods used to determine blood pressure. Office vs mean 24-hour automated blood pressures. , 1992, Archives of internal medicine.

[3]  N. Blakeman,et al.  The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients , 1994, Journal of hypertension.

[4]  M. Urdea,et al.  Principles of Economic Analysis of Health Care Technology , 1996, Annals of Internal Medicine.

[5]  P. Semple,et al.  Detection and treatment of renovascular disease: 40 years on. , 1994, Journal of hypertension.

[6]  L. Wilhelmsen,et al.  Prevalence of primary and secondary hypertension: studies in a random population sample. , 1976, British medical journal.

[7]  K. Mclaughlin.  Effect of renal-artery stenting on progression of renovascular renal failure , 1997, The Lancet.

[8]  G. Chatellier,et al.  Restenosis after a first percutaneous transluminal renal angioplasty. , 1993, Hypertension.

[9]  Novick Ac.  Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. , 1997 .

[10]  A. Melander,et al.  Comparison of dose standard units for drug utilisation studies , 1996, European Journal of Clinical Pharmacology.

[11]  F H Derkx,et al.  Renal artery stenosis and hypertension. , 1994, Lancet.

[12]  I. Miyamori,et al.  Comparative effects of captopril and nifedipine on split renal function in renovascular hypertension. , 1988, American journal of hypertension.

[13]  A. Shore,et al.  Microvascular function in human essential hypertension. , 1994, Journal of hypertension.

[14]  J. Laragh,et al.  RECURRENT PULMONARY OEDEMA IN HYPERTENSION DUE TO BILATERAL RENAL ARTERY STENOSIS: TREATMENT BY ANGIOPLASTY OR SURGICAL REVASCULARISATION , 1988, The Lancet.

[15]  S. Wagner,et al.  Effect of age on response of secondary hypertension to specific treatment. , 1990, American journal of hypertension.

[16]  F P Cappuccio,et al.  Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. , 1994, The American journal of medicine.

[17]  P. Waller,et al.  Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. , 1990, BMJ.

[18]  M. Schalekamp,et al.  Renal artery stenosis and hypertension , 1994, The Lancet.

[19]  M. Blaufox,et al.  Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program. , 1985, Archives of internal medicine.

[20]  N. Madias,et al.  Percutaneous Transluminal Renal Angioplasty in Management of Atherosclerotic Renovascular Hypertension: Results in 100 Patients , 1989, Hypertension.

[21]  C. Wilcox,et al.  Newer tests for the diagnosis of renovascular disease. , 1992, JAMA.

[22]  P. Weidmann,et al.  Complications in percutaneous transluminal dilatation of renal arteries. , 1986, Nephron.

[23]  Jeffrey Rimmer,et al.  Atherosclerotic Renovascular Disease and Progressive Renal Failure , 1993, Annals of Internal Medicine.

[24]  L. Ramsay,et al.  IS "IMPROVEMENT" REAL WITH PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY IN THE MANAGEMENT OF RENOVASCULAR HYPERTENSION? , 1987, The Lancet.

[25]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .